Localized skin necrosis of steroid-induced striae distensae: an unusual complication of bevacizumab and irinotecan therapy

Arch Dermatol. 2011 Oct;147(10):1227-8. doi: 10.1001/archdermatol.2011.311.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Bevacizumab
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / radiotherapy
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use
  • Chemoradiotherapy
  • Fatal Outcome
  • Glioblastoma / drug therapy
  • Glioblastoma / radiotherapy
  • Humans
  • Irinotecan
  • Male
  • Methylprednisolone Hemisuccinate / adverse effects*
  • Methylprednisolone Hemisuccinate / therapeutic use
  • Necrosis
  • Skin / drug effects*
  • Striae Distensae / chemically induced
  • Striae Distensae / pathology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab
  • Methylprednisolone Hemisuccinate
  • Irinotecan
  • Camptothecin